Purple Biotech (PPBT) Other Non Operating Income (2014 - 2025)
Purple Biotech (PPBT) reported Other Non Operating Income of $61000.0 for Q4 2025, up 180.26% year-over-year from $21765.3 in Q4 2024, and up 180.26% quarter-over-quarter from -$76000.0 in Q4 2024.
Purple Biotech (PPBT) Other Non Operating Income (2014 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 9 years of Other Non Operating Income data on file, last reported at $61000.0 in Q4 2025.
- Other Non Operating Income for Q4 2025 came in at $61000.0, up 180.26% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.8 million (up 55.9% YoY), and the FY2025 annual result was $1.5 million, down 54.38% from the prior year.
- Other Non Operating Income grew to $61000.0 in Q4 2025 per PPBT's latest filing, from -$76000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $61000.0 in Q4 2025 and troughed at -$3.5 million in Q4 2023.
- A 3-year average of -$1.3 million and a median of -$946000.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income surged 97.83% in 2024, then surged 180.26% in 2025.
- A 3-year view of Other Non Operating Income shows it stood at -$3.5 million in 2023, then surged by 97.83% to -$76000.0 in 2024, then surged by 180.26% to $61000.0 in 2025.
- Business Quant data shows PPBT's Other Non Operating Income at $61000.0 in Q4 2025, -$76000.0 in Q4 2024, and -$1.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Sep 30, 2024 | -1.85 Mn |
| Jun 30, 2024 | -946,000.00 |
| Dec 31, 2023 | -3.50 Mn |
| Dec 31, 2019 | -517,000.00 |
| Dec 31, 2018 | -3.20 Mn |
| Dec 31, 2017 | 1.05 Mn |
| Dec 31, 2016 | 5.02 Mn |
| Dec 31, 2015 | -94,000.00 |
| Dec 31, 2014 | -274,000.00 |